This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.03% per year. These returns cover a period from January 1, 1988 through July 1, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Weak Volumes & Cost Hurt Molson Coors, Growth Efforts on Track
by Zacks Equity Research
Molson Coors (TAP) is grappling with weakness in volumes and high input cost. However, the company's solid brand portfolio, premiumization efforts and cost-saving initiatives bode well.
FEMSA's (FMX) Unit Acquires AGV, Expands Footprint in Brazil
by Zacks Equity Research
FEMSA's (FMX) subsidiary, Solictica completes the acquisition of AGV. This is an important step for Solistica's Brazilian strategy.
Is Coca-Cola (CCEP) a Potential Stock for Value Investors?
by Zacks Equity Research
Let's see if Coca-Cola (CCEP) stock is a good choice for value-oriented investors right now from multiple angles.
CCEP or PEP: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
CCEP vs. PEP: Which Stock Is the Better Value Option?
KOF vs. CCEP: Which Stock Is the Better Value Option?
by Zacks Equity Research
KOF vs. CCEP: Which Stock Is the Better Value Option?
Coca-Cola European (CCEP) Reports Next Week: What to Know Ahead of the Release
by Zacks Equity Research
Coca-Cola European (CCEP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Soft Drinks Outlook: Can Portfolio Shift Bring Back the Fizz?
by Zacks Equity Research
The soft drinks space continues to struggle due to higher costs and soft carbonated-drinks sales. Meanwhile, companies' efforts to skew their portfolio toward health drinks and juices should help.
Keurig (KDP) Q4 Earnings In Line, Stock Slips on Soft View
by Zacks Equity Research
Keurig Dr Pepper (KDP) posts mixed fourth-quarter 2018 results, with sales missing estimates and earnings in line. A lower-than-expected earnings view for 2019 hurts investor sentiment.
PepsiCo to Boost Nutrition Portfolio With CytoSport Buyout
by Zacks Equity Research
PepsiCo (PEP) aims to fortify the nutrition brands portfolio with Hormel's CytoSport business, which produces Muscle Milk.
PepsiCo (PEP) Q4 Earnings In Line, Sales Beat Estimates
by Zacks Equity Research
PepsiCo (PEP) reports in-line earnings in fourth-quarter 2018 while sales top estimates. Strong performances in international divisions, along with strength in FLNA and NAB segments, boost results.
Coca-Cola (KO) Q4 Earnings In Line, Stock Slips on Soft View
by Zacks Equity Research
Coca-Cola (KO) delivers in-line earnings and sales in fourth-quarter 2018. However, concerns regarding increased impacts of currency fluctuations are likely to mar results in 2019.
CCEP or CCHGY: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
CCEP vs. CCHGY: Which Stock Is the Better Value Option?
What to Expect From These 5 Soft Drinks Stocks' Q4 Earnings?
by Zacks Equity Research
Let's see what is in store for a few soft drinks beverage stocks that are lined up for earnings releases this week.
Can Coca-Cola (KO) Keep Earnings Beat Trend Alive in Q4?
by Zacks Equity Research
Coca-Cola (KO) persistently gains from ongoing productivity efforts and disciplined growth strategies. Further, investment and innovation in the sparkling soft drinks category should aid results.
New Strong Buy Stocks for February 7th
by Tirthankar Chakraborty
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Thursday
Can Molson Coors (TAP) Brave Industry Woes in Q4 Earnings?
by Zacks Equity Research
Molson Coors (TAP) displays strength on the back of gains from cost-saving and premiumization efforts. However, soft industry trends, higher input costs and adverse currency remain concerns.
Avon (AVP) Eyes Turnaround, Reduces Headcount and Inventory
by Zacks Equity Research
Avon (AVP) moves ahead with the 'Open Up' Avon strategy as it plans to reset operating structure by reducing inventory levels and Stock Keeping Units, alongside lowering global headcount.
Diageo (DEO) Posts Strong 1H19 Earnings, Ups FY19 Sales View
by Zacks Equity Research
Diageo (DEO) reports strong top and bottom-line results for the first half of fiscal 2019, backed by solid organic growth. Further, the outlook for fiscal 2019 remains robust.
Coca-Cola Completes Buyout of Nigeria's Dairy & Juice Maker
by Zacks Equity Research
Coca-Cola (KO) acquires full stake in Nigeria's dairy and juice maker, Chi Ltd. Notably, Chi's diversified portfolio should aid the company's expansion in new categories and strengthen its business in Africa.
CCEP vs. CCHGY: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
CCEP vs. CCHGY: Which Stock Is the Better Value Option?
3 Soft Drinks Stocks With Potential to Beat Earnings in Q4
by Zacks Equity Research
The soft drinks industry's Q4 results might persistently bear the impact of soft CSD trends, and higher raw material and transportation costs. However, there are some potential winners in this space.
Why Coca-Cola European (CCEP) Could Beat Earnings Estimates Again
by Zacks Equity Research
Coca-Cola European (CCEP) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
New Strong Buy Stocks for January 18th
by Tirthankar Chakraborty
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Friday
CCEP vs. CCHGY: Which Stock Is the Better Value Option?
by Zacks Equity Research
CCEP vs. CCHGY: Which Stock Is the Better Value Option?